Skip to search formSkip to main contentSkip to account menu

fantofarone

Known as: 2-isopropyl-1-((4-(3-(N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino)propoxy)benzenesulfonyl))indolizine, Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)- 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Calcium Channel BlockersEnzyme InhibitorsIndolizinesPhenethylamines

Narrower (1)

SR 33557

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
De novo C16‐ and C24‐ceramide generation contributes to spontaneous neutrophil apoptosis
Neutrophils rapidly undergo spontaneous apoptosis following their release from the bone marrow. Although central to leukocyte… 
1998
1998
Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
1997
1997
Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker.
Mibefradil is a novel Ca2+ antagonist acting on both L- and T-type Ca2+ channels, with a ten-fold selectivity for T-type Ca2… 
Review
1995
Review
1995
New drug binding sites in Ca2+ channels.
1995
1995
Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury.
1995
1995
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
1994
1994
Binding of fantofarone, a novel Ca2+ antagonist, to serum albumin: a fluorescence study.
Using the fluorescent properties of fantofarone, we have studied the interactions between this novel calcium entry blocker and… 
1994
1994
Effects of a new class of calcium antagonists, SR33557 (fantofarone) and SR33805, on neuronal voltage-activated Ca++ channels.
SR33557 (fantofarone) and SR33805 are structurally novel calcium antagonists that bind selectively to the alpha 1-subunit of the… 
1994
1994
Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
1993
1993
In vitro characterization of a novel Ca2+ entry blocker: SR 33805.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)